SPRC logo

SciSparc Ltd.

SPRC
Healthcare|Biotechnology|IL
$0.42
-0.01 (-2.45%)
Cash / Share
$8.01
Financing Filings (last 12 months)
5
Shelf registrations / offering prospectuses — latest Aug 19, 2026 (F-3/A). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome
Oct 22, 2026 · GlobeNewsWire
SciSparc Shifts Focus to Agentic AI, Targeting Cybersecurity and Finance Applications
Oct 19, 2026 · GlobeNewsWire
SciSparc Announces Transformation into Agentic AI-Powered Technologies, Including Cybersecurity and Finance Technologies
Oct 15, 2026 · GlobeNewsWire
SciSparc: Subsidiary NeuroThera Labs' CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company's Quantum Architecture
Oct 7, 2026 · GlobeNewsWire
SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations
Sep 23, 2026 · GlobeNewsWire
SciSparc: Subsidiary NeuroThera Labs Achieves Significant Enrollment Momentum in SCI‑210 Autism Clinical Trial
Aug 31, 2026 · GlobeNewsWire
SciSparc Advances Agentic AI Strategy with Addition of Internationally Recognized AI Expert Prof. Carmel Domshlak to Scientific Advisory Board
Aug 26, 2026 · GlobeNewsWire
SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
Aug 24, 2026 · GlobeNewsWire
SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc's Stake Valued at Approximately C$30 Million
Aug 18, 2026 · GlobeNewsWire
SciSparc's Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination
Aug 12, 2026 · GlobeNewsWire

SEC Filings (122)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 3, 20266-KForeign issuer reportDocumentIndex
Oct 26, 20266-KForeign issuer reportDocumentIndex
Oct 23, 20266-KForeign issuer reportDocumentIndex
Oct 15, 20266-KForeign issuer reportDocumentIndex
Oct 15, 20266-KForeign issuer reportDocumentIndex
Oct 7, 20266-KForeign issuer reportDocumentIndex
Sep 30, 20266-KForeign issuer reportDocumentIndex
Sep 24, 20266-KForeign issuer reportDocumentIndex
Sep 2, 20266-KForeign issuer reportDocumentIndex
Aug 31, 2026EFFECTDocumentIndex
Aug 26, 20266-KForeign issuer reportDocumentIndex
Aug 24, 20266-KForeign issuer reportDocumentIndex
Aug 19, 2026F-3/AShelf registrationDocumentIndex
Aug 19, 202620-F/AAnnual report (foreign)DocumentIndex
Aug 18, 20266-KForeign issuer reportDocumentIndex
Aug 12, 20266-KForeign issuer reportDocumentIndex
Aug 5, 20266-KForeign issuer reportDocumentIndex
Jul 31, 20266-KForeign issuer reportDocumentIndex
Jul 29, 20266-KForeign issuer reportDocumentIndex
Jul 15, 20266-KForeign issuer reportDocumentIndex
Jun 4, 20266-KForeign issuer reportDocumentIndex
May 29, 20266-KForeign issuer reportDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 11, 20266-KForeign issuer reportDocumentIndex
Apr 29, 202620-FAnnual report (foreign)DocumentIndex
Mar 16, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 16, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 16, 20266-KForeign issuer reportDocumentIndex
Mar 12, 20266-KForeign issuer reportDocumentIndex
Mar 9, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 2, 20266-KForeign issuer reportDocumentIndex
Feb 17, 2026F-3Shelf registrationDocumentIndex
Feb 17, 20266-KForeign issuer reportDocumentIndex
Feb 12, 2026EFFECTDocumentIndex
Feb 12, 20266-KForeign issuer reportDocumentIndex
Feb 4, 20266-KForeign issuer reportDocumentIndex
Feb 3, 2026F-3Shelf registrationDocumentIndex
Feb 2, 20266-KForeign issuer reportDocumentIndex
Jan 26, 2026S-8Employee stock planDocumentIndex
Jan 26, 20266-KForeign issuer reportDocumentIndex